Journal
JOURNAL OF IMMUNOLOGY
Volume 164, Issue 12, Pages 6100-6104Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.164.12.6100
Keywords
-
Categories
Ask authors/readers for more resources
The nonpolymorphic soluble HLA-G1 (sHLA-G1) isoform has been reported to be secreted by trophoblast cells at the materno fetal interface, suggesting that it may act as immunomodulator during pregnancy. In this paper, we report that affinity-purified beta(2)-microglobulin-associated sHLA-G1 triggered apoptosis in activated, but not resting CD8(+) peripheral blood cells, We demonstrate by Western blotting that sHLA-G1 enhanced CD95 ligand expression in activated CD8+ cells. Cytotoxicity was inhibited by preincubation of the cells with a CD95 antagonist mAb (ZB4) or a soluble recombinant CD95-Fc, indicating that apoptosis is mediated through the Cn95/CD95 ligand pathway, Finally, we show that such sHLA-G1-induced apoptosis depends on the interaction with CDS molecules, with cell death being blocked by various CD8 mAbs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available